Deborah Weinshwig of CoreSight Research Group observes that consumers are showing less willingness to trade down from preferred retail stores or from branded products to private labels.

The widespread use of GLP-1 medications is creating a significant shift in consumer apparel demand, with 70% of users changing two or more clothing sizes and 50% purchasing new clothing as a result.

One-fifth of the U.S. population is currently on or has been on GLP-1 drugs.

According to a weekly survey by CoreSight Research Group, 40.4% of consumers state that tariffs are on their mind.

Retailers are increasingly using AI for demand forecasting and inventory allocation to adapt to rapid changes in consumer sizes, with some exploring a "zero inventory" model.

The use of GLP-1 drugs has negatively impacted sales for athletic apparel and footwear companies because they have not had enough inventory of smaller sizes.

Approximately 70% of consumers on GLP-1 drugs are changing their clothing size by two sizes or more, with 50% of the total user base purchasing new clothing as a result.